Observational study of the effects of probenecid on the pharmacokinetics and pharmacodynamics of sorafenib (PROSORA-study)
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Probenecid (Primary) ; Sorafenib (Primary)
- Indications Liver cancer; Renal cell carcinoma; Thyroid cancer
- Focus Pharmacokinetics
- Acronyms PROSORA
- 29 Nov 2017 New trial record